Maravai LifeSciences Holdings MRVI
$ 5.35
-1.57%
Quarterly report 2024-Q3
added 11-12-2024
Country |
USA |
IPO year |
2020 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
|
Employees in the company |
- |
Shares |
132 M |
Market Cap[1] |
$ 706 M |
EBITDA (LTM) |
$ -193 M |
P/E (LTM) |
-6.36 |
P/S (LTM) |
2.77 |
EPS (LTM) |
-0.89 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.